Amorchem
TagSemaThera scores $2.6 million and a licensing deal for China and Japan
SemaThera, a Montreal-based biotechnology startup, announced it has raised $2.6 million to prepare the company’s lead drug, ST-102, for cl..
AmorChem launches $44.2 million seed-stage biotech investment fund
It’s a good day for Quebec’s biotech industry.
Today AmorChem launched a seed-stage biotechnology investment fund, AmorChem II, at an i..
Life science VC firm Amorchem spins out two new startups
AmorChem has invested in and spun out two new startups devoted to tackling inflammation and ocular diseases.
The VC firm separately fun..